Richard Malamut Selected Research

Hydrocodone (Dihydrocodeinone)

1/2017	Evaluation of Quality of Life, Functioning, Disability, and Work/School Productivity Following Treatment with an Extended-Release Hydrocodone Tablet Formulated with Abuse-Deterrence Technology: A 12-month Open-label Study in Patients with Chronic Pain.
5/2016	Six-month, open-label study of hydrocodone extended release formulated with abuse-deterrence technology: Safety, maintenance of analgesia, and abuse potential.
11/2015	Efficacy and safety of a hydrocodone extended-release tablet formulated with abuse-deterrence technology in patients with moderate-to-severe chronic low back pain.
9/2015	Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.
1/2015	Efficacy and tolerability of a hydrocodone extended-release tablet formulated with abuse-deterrence technology for the treatment of moderate-to-severe chronic pain in patients with osteoarthritis or low back pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard Malamut Research Topics

Disease

12	Pain (Aches) 01/2021 - 05/2012
8	Chronic Pain 01/2021 - 05/2012
5	Low Back Pain (Lumbago) 01/2021 - 01/2015
3	Postherpetic Neuralgia 01/2021 - 07/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 07/2015
2	Postoperative Pain 01/2021 - 07/2015
2	Virus Diseases (Viral Diseases) 01/2021 - 07/2015
1	Sensorineural Hearing Loss 05/2016
1	Constipation 11/2015
1	Nausea 11/2015
1	Opioid-Related Disorders (Opiate Addiction) 09/2015
1	Osteoarthritis 01/2015

Drug/Important Bio-Agent (IBA)

6	Opioid Analgesics (Opioids)IBA 10/2016 - 10/2012
5	Hydrocodone (Dihydrocodeinone)FDA LinkGeneric 01/2017 - 01/2015
3	TabletsIBA 01/2017 - 01/2015
3	Analgesics (Analgesic Drugs)IBA 11/2016 - 01/2015
3	Pharmaceutical PreparationsIBA 11/2015 - 01/2015
2	ElementsIBA 01/2021 - 07/2015
2	Abuse-Deterrent FormulationsIBA 10/2016 - 01/2016
1	Ointments (Pastes)IBA 01/2017
1	TV-45070IBA 01/2017
1	Sodium Channel BlockersIBA 01/2017
1	IceIBA 11/2016
1	Prostaglandins AIBA 09/2015

Therapy/Procedure

2	Secondary Prevention 01/2021 - 07/2015
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2015
2	Therapeutics 09/2016 - 05/2012
1	Analgesia 05/2016